Voltar
Carta Acesso aberto Produção Nacional Revisado por pares
BIBTEX RIS

N-acetylcysteine in the treatment of skin-picking disorder

2014; Associação Brasileira de Psiquiatria; Volume: 36; Issue: 1 Linguagem: Inglês

10.1590/1516-4446-2013-1154

ISSN

1809-452X

Autores

Regina Silva-Netto, Gustavo Nobre de Jesus, Marcelo Saito Nogueira, Hermano Tavares,

Tópico(s)

Parkinson's Disease Mechanisms and Treatments

Resumo

N-acetylcysteine (NAC) is a precursor to the amino acid cysteine, a modulator of the glutamatergic system.Thus, NAC may exert a therapeutic effect in several psychiatric disorders, namely schizophrenia and affective disorders, 1 as well as symptoms and syndromes of the obsessiveimpulsive spectrum (e.g., trichotillomania and other grooming disorders, pathological gambling, and substance misuse 2 ).There is only one published case report of treatment of skin-picking disorder with NAC. 3 No controlled studies or case series of this treatment have been reported.Below, we report three cases treated at our Impulse Control Disorder clinic of patients who, among other disorders, presented with skin picking.Case 1.A 45-year-old woman was diagnosed with depressive episode, trichotillomania, and skin picking (history of hair-pulling since she was 4 years old).She was started on sertraline up to 100 mg/day, with no improvement in mood or grooming disorder, then switched to venlafaxine 75 mg/day.At that time, she was also given NAC 1,200 mg/day.Her mood and trichotillomania improved partially and the skin picking resolved completely.Following this improvement, she decided to discontinue her medications unilaterally, with subsequent worsening of all symptoms.In December 2011, she was restarted on venlafaxine 75 mg/day and NAC 1,800 mg/day, with improvement of depressive symptoms and trichotillomania and complete recovery from skin picking.Case 2. A 40-year-old woman complained of excessive buying coupled with irritability, pressured speech, inflated self-esteem, and inadequate behavior.At the time of presentation, she was on haloperidol 2.5 mg/day, biperiden 2 mg/day, imipramine 25 mg/day, and diazepam 10 mg/day.There was no history of alcohol or illicit drug use.All medications were discontinued and she was started on lithium 600 mg/day (up to 1,200 mg/day) and quetiapine 50 mg/day (up to 500 mg/day).One month later, she developed skin picking, despite good mood

Referência(s)